Weschenfelder Camila, Berryman Claire E, Hennigar Stephen R
Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA, 70808, USA.
Curr Diab Rep. 2025 Jun 3;25(1):34. doi: 10.1007/s11892-025-01589-z.
To assess the current literature on iron intake in relation to obesity and its comorbidities. Specifically, to evaluate the potential mechanisms and the strength of the evidence linking heme iron intake to these conditions, highlight methodological challenges in assessing iron intake, and identify gaps that warrant further investigation.
Studies were mostly prospective cohorts. Across studies, total, heme and non-heme iron intakes were associated with both increased and decreased risk in relation to outcomes, which may be due to differences in the population being investigated and methods used to estimate the heme iron content of foods. The evidence concerning total, heme and non-heme dietary iron is inconclusive when evaluating its associations with obesity and comorbidities. Well-designed clinical trials are needed to better inform nutrition guidelines. Additionally, quantification of total, heme and non-heme iron in foods is essential to improve dietary assessments and strengthen research on their potential impact on health.
评估目前有关铁摄入量与肥胖及其合并症关系的文献。具体而言,评估将血红素铁摄入量与这些情况联系起来的潜在机制和证据强度,强调评估铁摄入量时的方法学挑战,并确定需要进一步研究的空白。
研究大多为前瞻性队列研究。在各项研究中,总铁、血红素铁和非血红素铁摄入量与结局的风险增加和降低均有关联,这可能是由于所研究人群的差异以及用于估计食物中血红素铁含量的方法不同所致。在评估膳食总铁、血红素铁和非血红素铁与肥胖及其合并症的关联时,证据尚无定论。需要设计良好的临床试验,以便为营养指南提供更充分的信息。此外,对食物中的总铁、血红素铁和非血红素铁进行量化,对于改善膳食评估以及加强对其潜在健康影响的研究至关重要。